Efficacy Study of Two Continuous Regimens of Oral Daily 5 mg or 10 mg of Ulipristal Acetate (UPA), Versus a Dose of 5.0mg UPA for 24/4 Days
NCT01953679
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
180
Enrollment
OTHER
Sponsor class
Conditions
Focus: Estrogen-free Oral Contraception
Interventions
DRUG:
Ulipristal Acetate
Sponsor
Premier Research
Collaborators
[object Object]